Pilot Study of Transcranial Stimulation (tDCS)to Relieve Neuropathic Pain in Cancer Patients

Completed · Not applicable · Has a placebo group

Conditions studied: Pain

In brief

This is a pilot study designed to collect preliminary data on safety and efficacy of transcranial direct current stimulation (tDCS) to relieve pain in cancer patients who developed neuropathic pain in the affected area after a surgical intervention, radiation therapy, or chemotherapy to treat the disease.

Key facts

Study ID

NCT01948050

Run by

Beth Israel Medical Center

People needed

24

Starts

2009-01-01

Expected to finish

2012-11-01

Last updated by the study team

2014-07-14

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pain on the side of the lesion
• Spontaneous pain with a score for "worst pain in the last 24 hours" >4 on a numeric scale 0-10
• Must present the following symptoms and signs:
• Continuous burning, shooting, or lancinating pain.
• Presence of hyperesthesia
• Presence of hyperalgesia (to pinprick) and/or allodynia (to light touch)

You may not qualify if…

• Uncontrolled hypertension, uncontrolled diabetes, uncontrolled cardiovascular disease
• Pain/painful conditions unrelated to the cancer or related treatment
• Pregnancy
• History of seizures/epilepsy
• Any implanted devices (e.g. a cardio stimulator, etc)
• Active illegal drug/alcohol abuse
• Unable to follow directions or complete tools in English

Where it is running

• Beth Isael Medical Center — New York, USA, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.